Growth Metrics

Cross Country Healthcare (CCRN) EBIT Margin (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed EBIT Margin for 16 consecutive years, with 12606.51% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 1260762.0% year-over-year to 12606.51%, compared with a TTM value of 10.33% through Dec 2025, down 908.0%, and an annual FY2025 reading of 3809.3%, up 381055.0% over the prior year.
  • EBIT Margin was 12606.51% for Q4 2025 at Cross Country Healthcare, up from 2.39% in the prior quarter.
  • Across five years, EBIT Margin topped out at 12606.51% in Q4 2025 and bottomed at 5.65% in Q2 2024.
  • Average EBIT Margin over 5 years is 634.29%, with a median of 5.58% recorded in 2021.
  • The sharpest move saw EBIT Margin plummeted -1216bps in 2024, then soared 1260762bps in 2025.
  • Year by year, EBIT Margin stood at 11.86% in 2021, then tumbled by -35bps to 7.68% in 2022, then plummeted by -58bps to 3.24% in 2023, then plummeted by -134bps to 1.11% in 2024, then soared by 1138248bps to 12606.51% in 2025.
  • Business Quant data shows EBIT Margin for CCRN at 12606.51% in Q4 2025, 2.39% in Q3 2025, and 2.14% in Q2 2025.